Dynavax to Host Analyst & Investor Day Webcast October 29, 2010

October 21, 2010 at 9:02 AM EDT

BERKELEY, CA, Oct 21, 2010 (MARKETWIRE via COMTEX News Network) -- Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it will webcast its first Analyst & Investor Day on Friday, October 29, 2010, from 8:00 - 11:00 am Eastern Time.

Presentation and discussions will focus on hepatitis B: epidemiology, unmet needs, and public/individual health Impacts, as well as the regulatory landscape and new market opportunities.

Guest speakers at the event will include: 

--  William Schaffner, M.D., Professor & Chairman, Department of
    Preventive Medicine, Division of Infectious Diseases, Vanderbilt
    University School of Medicine.
--  Florian Schoedel, M.D., PhD, formerly Merck VP, Infectious
    Diseases / Vaccines Clinical Research.
--  Peter Patriarca, M.D., formerly, FDA Director, Division of Viral
    Products, Office of Vaccines Research & Review in the Center for
    Biologics Evaluation & Research (CBER).
--  Stanley Plotkin, M.D., Emeritus Professor of Pediatrics and
    Microbiology, University of Pennsylvania.

Presentations by Dynavax's Dr. Tyler Martin, President and Chief Medical Officer; Dr. Robert Coffman, Chief Scientific Officer; Brant Biehn, Chief Commercial Officer; and Dr. Dino Dina, Chief Executive Officer will also be broadcast. To access the live webcast and the subsequent archived audio recording of the presentation, please log onto Dynavax's website at http://investors.dynavax.com/newsevents.cfm.

About Dynavax

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases. The company's lead product candidate is HEPLISAV, an investigational adult hepatitis B vaccine designed to enhance protection more rapidly and with fewer doses than current licensed vaccines. For more information visit www.dynavax.com. 

Contact:
Shari Annes
Investor Relations
510-665-7211
Email Contact

SOURCE: Dynavax Technologies 

http://www2.marketwire.com/mw/emailprcntct?id=BFD04CA1527A623C

Copyright 2010 Marketwire, Inc., All rights reserved.

News Provided by COMTEX